MORONI, Emanuela
 Distribuzione geografica
Continente #
NA - Nord America 837
EU - Europa 733
AS - Asia 211
OC - Oceania 3
SA - Sud America 3
AF - Africa 1
Totale 1.788
Nazione #
US - Stati Uniti d'America 836
PL - Polonia 500
CN - Cina 121
UA - Ucraina 80
DE - Germania 47
VN - Vietnam 32
HK - Hong Kong 26
FI - Finlandia 24
ES - Italia 19
IT - Italia 16
SG - Singapore 14
GB - Regno Unito 13
IE - Irlanda 13
IN - India 9
CZ - Repubblica Ceca 8
FR - Francia 6
IR - Iran 5
SE - Svezia 3
AU - Australia 2
BO - Bolivia 1
BR - Brasile 1
CA - Canada 1
CL - Cile 1
DK - Danimarca 1
HU - Ungheria 1
JP - Giappone 1
KR - Corea 1
MA - Marocco 1
MD - Moldavia 1
NL - Olanda 1
NZ - Nuova Zelanda 1
PH - Filippine 1
TR - Turchia 1
Totale 1.788
Città #
Warsaw 500
Fairfield 140
Woodbridge 101
Ashburn 87
Houston 65
Jacksonville 61
Seattle 51
Cambridge 50
Wilmington 44
Chandler 40
Ann Arbor 35
Dong Ket 31
Beijing 28
Hong Kong 26
Princeton 25
Nanjing 20
Madrid 19
New York 17
Jinan 14
Dublin 13
Helsinki 12
Singapore 12
Nanchang 11
Haikou 7
Shenyang 7
Dearborn 6
Rome 6
San Diego 6
Boardman 5
Shanghai 5
Des Moines 4
Hebei 4
Olomouc 4
Phoenix 4
Ardabil 3
Augusta 3
Brescia 3
Brno 3
Changsha 3
Jiaxing 3
Kunming 3
Lanzhou 3
Los Angeles 3
Munich 3
San Mateo 3
Santa Clara 3
Washington 3
Changchun 2
Chiswick 2
Fuzhou 2
Milan 2
San Francisco 2
Wandsworth 2
Zhengzhou 2
Amsterdam 1
Auckland 1
Canberra 1
Chisinau 1
Goodlettsville 1
Guangzhou 1
Gunzenhausen 1
Hangzhou 1
Leipzig 1
London 1
Monmouth Junction 1
Nashville 1
Ningbo 1
Norwalk 1
Prague 1
Quezon City 1
Rabat 1
Sabz 1
Segrate 1
Seoul 1
Sucre 1
Sydney 1
São Paulo 1
Taiyuan 1
Tianjin 1
Tokyo 1
Toronto 1
Verona 1
Wickede 1
Totale 1.542
Nome #
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. 245
Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor. 229
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 219
Gremlin is a novel agonist of the major pro-angiogenic receptor VEGFR2 214
Angiopoietin-1 mediates the pro-angiogenic activity of the bone morphogenic protein antagonist Drm 211
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE MORPHOGENIC PROTEIN ANTAGONIST DRM 124
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE-MORPHOGENIC PROTEIN ANTAGONIST DRM 111
Cutting edge: proangiogenic properties of alternatively activated dendritic cells. 98
Fibroblast growth factor-2 in angiogenesis 91
Osteopontin overexpression inhibits in vitro re-endothelialization via integrin engagement 82
Osteopontin overexpression inhibits in vitro re-endothelialization via integrin engagement. 68
THE CYSTINE-KNOT PROTEIN GREMLIN IS A NOVEL AGONIST OF THE MAJOR PRO-ANGIOGENIC RECEPTOR VEGFR2 59
In Situ DNA/Protein Interaction Assay to Visualize Transcriptional Factor Activation 59
Totale 1.810
Categoria #
all - tutte 5.858
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.858


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020569 60 33 32 62 44 57 61 54 44 64 33 25
2020/2021355 14 28 18 39 18 42 14 36 38 30 28 50
2021/2022124 2 27 0 1 3 7 6 8 7 23 5 35
2022/2023108 19 11 9 5 6 22 0 3 18 1 4 10
2023/2024177 9 15 23 9 5 36 2 9 29 9 4 27
2024/20255 5 0 0 0 0 0 0 0 0 0 0 0
Totale 1.810